JMC publication and front cover from #CHDI and #CharlesRiver team on Highly selective Rho kinase inhibitors as neuroprotective agents against Huntington's disease. #teamwork, #cureHD.
@ACS4Authors, #MyACSCover.
https://t.co/zPo9oekx7V.
https://t.co/4VOBULQ6nO